Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Scott

Showing results (21-30 of 159) with videos related to

Pageof 16
Sort By:
Drug and Alcohol Dependence|July 11, 2014
Are users' most recent drug purchases representative?Brittany Bond, Jonathan P Caulkins, Nick Scott, et al.
BMC Infectious Diseases|June 2, 2022
The impact of three progressively introduced interventions on second wave daily COVID-19 case numbers in Melbourne, AustraliaAllan Saul, Nick Scott, Tim Spelman, et al.
Addiction (Abingdon, England)|September 16, 2014
High-frequency drug purity and price series as tools for explaining drug trends and harms in Victoria, AustraliaNick Scott, Jonathan P Caulkins, Alison Ritter, et al.
Australian and New Zealand Journal of Public Health|August 16, 2016
Limited provision of diagnostic services to Victorians living with hepatitis C antibodies, 2001-2012: a multi-level modelling analysisKathryn Snow, Nick Scott, Hazel J Clothier, et al.
BMC Medicine|November 23, 2019
Profiling Mycobacterium tuberculosis transmission and the resulting disease burden in the five highest tuberculosis burden countriesRomain Ragonnet, James M Trauer, Nicholas Geard, et al.
Addiction (Abingdon, England)|August 10, 2020
Prevalence and correlates of simultaneous, multiple substance injection (co-injection) among people who inject drugs in Melbourne, AustraliaAnna Palmer, Peter Higgs, Nick Scott, et al.
BMC Global and Public Health|January 21, 2026
Estimating the impact of decreasing vaccination response times for outbreaks of vaccine-preventable diseases in low- and middle-income countriesDominic Delport, Alina M Muellenmeister, Jane Greig, et al.
The International Journal on Drug Policy|May 4, 2016
The effects of extended public transport operating hours and venue lockout policies on drinking-related harms in Melbourne, Australia: Results from SimDrink, an agent-based simulation modelNick Scott, Aaron Hart, James Wilson, et al.
The International Journal on Drug Policy|December 29, 2019
Upscaling prevention, testing and treatment to control hepatitis C as a public health threat in Dar es Salaam, Tanzania: A cost-effectiveness modelNick Scott, Zameer Mohamed, John Rwegasha, et al.
Gut|May 20, 2016
Treatment scale-up to achieve global HCV incidence and mortality elimination targets: a cost-effectiveness modelNick Scott, Emma S McBryde, Alexander Thompson, et al.
Pageof 16

Showing results (21-30 of 159) with videos related to

Sort By:
Pageof 16
Drug and Alcohol Dependence|July 11, 2014
Are users' most recent drug purchases representative?Brittany Bond, Jonathan P Caulkins, Nick Scott, et al.
BMC Infectious Diseases|June 2, 2022
The impact of three progressively introduced interventions on second wave daily COVID-19 case numbers in Melbourne, AustraliaAllan Saul, Nick Scott, Tim Spelman, et al.
Addiction (Abingdon, England)|September 16, 2014
High-frequency drug purity and price series as tools for explaining drug trends and harms in Victoria, AustraliaNick Scott, Jonathan P Caulkins, Alison Ritter, et al.
Australian and New Zealand Journal of Public Health|August 16, 2016
Limited provision of diagnostic services to Victorians living with hepatitis C antibodies, 2001-2012: a multi-level modelling analysisKathryn Snow, Nick Scott, Hazel J Clothier, et al.
BMC Medicine|November 23, 2019
Profiling Mycobacterium tuberculosis transmission and the resulting disease burden in the five highest tuberculosis burden countriesRomain Ragonnet, James M Trauer, Nicholas Geard, et al.
Addiction (Abingdon, England)|August 10, 2020
Prevalence and correlates of simultaneous, multiple substance injection (co-injection) among people who inject drugs in Melbourne, AustraliaAnna Palmer, Peter Higgs, Nick Scott, et al.
BMC Global and Public Health|January 21, 2026
Estimating the impact of decreasing vaccination response times for outbreaks of vaccine-preventable diseases in low- and middle-income countriesDominic Delport, Alina M Muellenmeister, Jane Greig, et al.
The International Journal on Drug Policy|May 4, 2016
The effects of extended public transport operating hours and venue lockout policies on drinking-related harms in Melbourne, Australia: Results from SimDrink, an agent-based simulation modelNick Scott, Aaron Hart, James Wilson, et al.
The International Journal on Drug Policy|December 29, 2019
Upscaling prevention, testing and treatment to control hepatitis C as a public health threat in Dar es Salaam, Tanzania: A cost-effectiveness modelNick Scott, Zameer Mohamed, John Rwegasha, et al.
Gut|May 20, 2016
Treatment scale-up to achieve global HCV incidence and mortality elimination targets: a cost-effectiveness modelNick Scott, Emma S McBryde, Alexander Thompson, et al.
Pageof 16